A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

An Australian-first study by the Registry of Senior Australians (ROSA) investigating the use of blood sugar-lowering medications among residents with diabetes in aged care homes nationwide, has ...

Two of the hottest trends in health — longevity medicine and weight loss drugs — are colliding. A theory that GLP-1 ...

Drugs such as Ozempic, Mounjaro, and Wegovy are showing effects well beyond weight loss and diabetes treatment, NOS reports.

The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.

Following the success of obesity treatments, global pharmaceutical and biotech industries are increasingly focusing on the ...

After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...

Credit: Getty Images Our easy-to-read fact sheets provide patients with an overview for type 2 diabetes medications that also induce weight loss. Our easy-to-read fact sheets provide clinicians with ...